Bulletin
Investor Alert

Horizon Therapeutics PLC

NAS: HZNP

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jan 30, 2023, 6:19 p.m.

/zigman2/quotes/206690250/composite

$

110.00

Change

-0.05 -0.05%

Volume

Volume 362,637

Quotes are delayed by 20 min

/zigman2/quotes/206690250/composite

Today's close

$ 110.63

$ 110.05

Change

-0.58 -0.52%

Day low

Day high

$110.04

$110.94

Open

52 week low

52 week high

$57.84

$117.49

Open

Insider Actions for Horizon Therapeutics PLC

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
01/11/2023 Jeffrey W. Sherman
EVP and Chief Medical Officer
3,368   Disposition at $113.1 per share. 380,920
01/10/2023 Jeffrey W. Sherman
EVP and Chief Medical Officer
3,368   Disposition at $113.05 per share. 380,752
01/06/2023 Jeffrey W. Sherman
EVP and Chief Medical Officer
5,187   Disposition at $113.29 per share. 587,635
01/05/2023 Timothy P. Walbert
Chairman, President and CEO; Director
97,461   Derivative/Non-derivative trans. at $113.24 per share. 11,036,483
01/05/2023 Michael A. DesJardin
EVP, Technical Operations
26,901   Derivative/Non-derivative trans. at $113.24 per share. 3,046,269
01/05/2023 Patrick McIlvenny
Chief Accounting Officer
4,147   Derivative/Non-derivative trans. at $113.24 per share. 469,606
01/05/2023 Timothy P. Walbert
Chairman, President and CEO; Director
219,995   Derivative/Non-derivative trans. at $0 per share. 0
01/05/2023 Michael A. DesJardin
EVP, Technical Operations
54,253   Derivative/Non-derivative trans. at $0 per share. 0
01/05/2023 Patrick McIlvenny
Chief Accounting Officer
7,973   Derivative/Non-derivative trans. at $0 per share. 0
01/01/2023 Timothy P. Walbert
Chairman, President and CEO; Director
46,365   Derivative/Non-derivative trans. at $113.8 per share. 5,276,337
01/01/2023 Jeffrey W. Sherman
EVP and Chief Medical Officer
9,717   Derivative/Non-derivative trans. at $113.8 per share. 1,105,794
01/01/2023 Michael A. DesJardin
EVP, Technical Operations
9,561   Derivative/Non-derivative trans. at $113.8 per share. 1,088,041
01/01/2023 Timothy P. Walbert
Chairman, President and CEO; Director
104,498   Derivative/Non-derivative trans. at $0 per share. 0
01/01/2023 Jeffrey W. Sherman
EVP and Chief Medical Officer
21,772   Derivative/Non-derivative trans. at $0 per share. 0
01/01/2023 Michael A. DesJardin
EVP, Technical Operations
21,772   Derivative/Non-derivative trans. at $0 per share. 0
12/30/2022 Andy Pasternak
EVP, Chief Strategy Officer
39,313   Derivative/Non-derivative trans. at $113.8 per share. 4,473,819
12/30/2022 Aaron L. Cox
EVP, Chief Financial Officer
28,758   Derivative/Non-derivative trans. at $113.8 per share. 3,272,660
12/30/2022 Elizabeth H. Z. Thompson
EVP, Research & Development
9,449   Derivative/Non-derivative trans. at $113.8 per share. 1,075,296
12/30/2022 Jeff Himawan
Director
2,230   Gift at $0 per share. 0
12/30/2022 Andy Pasternak
EVP, Chief Strategy Officer
88,733   Derivative/Non-derivative trans. at $0 per share. 0
12/30/2022 Aaron L. Cox
EVP, Chief Financial Officer
64,906   Derivative/Non-derivative trans. at $0 per share. 0
12/30/2022 Elizabeth H. Z. Thompson
EVP, Research & Development
19,055   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2022 Aaron L. Cox
EVP, Chief Financial Officer
4,774   Gift at $0 per share. 0
12/13/2022 Andy Pasternak
EVP, Chief Strategy Officer
6,918   Disposition at $112.6 per share. 778,966
12/13/2022 Andy Pasternak
EVP, Chief Strategy Officer
23,251   Disposition at $112.61 per share. 2,618,295
12/13/2022 Andy Pasternak
EVP, Chief Strategy Officer
23,251   Derivative/Non-derivative trans. at $29.52 per share. 686,369
12/12/2022 Jeffrey W. Sherman
EVP and Chief Medical Officer
21,378   Disposition at $111.45 per share. 2,382,578
12/12/2022 Jeffrey W. Sherman
EVP and Chief Medical Officer
6,974   Disposition at $111.44 per share. 777,182
11/01/2022 Andy Pasternak
EVP, Chief Strategy Officer
5,503   Derivative/Non-derivative trans. at $63.18 per share. 347,679
11/01/2022 Andy Pasternak
EVP, Chief Strategy Officer
12,421   Derivative/Non-derivative trans. at $0 per share. 0

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
11 Purchases
19 Sales
638,629
354,623
Last 6 months
12 Purchases
19 Sales
639,374
354,623
Last 12 months
42 Purchases
86 Sales
1,463,307
1,614,304

Officers and Executives

Mr. Timothy P. Walbert
Chairman, President & Chief Executive Officer
Mr. Aaron L. Cox
Chief Financial Officer & Executive Vice President
Dr. Karin Rosen
Chief Scientific Officer
Dr. Elizabeth H. Z. Thompson
Executive Vice President-Research & Development
Dr. Jeffrey W. Sherman
Chief Medical Officer & Executive Vice President
Mr. Michael A. DesJardin
Executive VP-Technical Operations & Quality
Dr. Jeffrey D. Kent
Executive VP-Medical Affairs & Outcomes Research
Mr. Andy Pasternak
Chief Strategy Officer & Executive Vice President
Ms. Holly Copeland
Senior Director-Corporate Social Responsibility
Ms. Marilyn Vetter
Group Vice President-Market Access
Mr. Vikram Karnani
President-International & Executive Vice President
Mr. Patrick McIlvenny
Chief Accounting Officer & Senior Vice President
Ms. Tina Ventura
Chief Investor Relations Officer & Senior VP
Ms. Jane Gonnerman
Chief of Staff & Group Vice President-Development
Ms. Irina P. Konstantinovsky
EVP, Chief Human Resources & Diversity Officer
Mr. David Caraher
Secretary
Mr. Sean M. Clayton
Executive Vice President & General Counsel
Dr. Susan Mahony
Independent Director
Mr. Michael G. Grey
Lead Independent Director
Dr. Jeff Himawan
Independent Director
Mr. William Francis Daniel
Independent Director
Ms. Pascale Witz
Independent Director
Dr. James Samuel Shannon
Independent Director
Mr. H. Thomas Watkins
Independent Director
Mr. Gino Santini
Independent Director
Link to MarketWatch's Slice.